Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes
Latest Information Update: 17 Jul 2024
At a glance
- Drugs Semaglutide (Primary)
- Indications Obesity; Prediabetic state
- Focus Therapeutic Use
- Acronyms HISTORI
- 08 Jul 2024 Status changed from recruiting to completed.
- 26 Apr 2024 Planned End Date changed from 30 Sep 2024 to 30 Dec 2024.
- 26 Apr 2024 Planned primary completion date changed from 31 Jan 2024 to 30 Sep 2024.